missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ TRPML1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA5111029
This item is not returnable.
View return policy
Description
Immunogen sequence: DTIKHPGGAG AEESELQAYI AQCQDSPTSG KFRRGSGSAC SLLCCCGRDP SE Highest antigen sequence indentity to the following orthologs: Mouse - 87%, Rat - 85%.
Defects in Mucolipin-1 are the cause of mucolipidosis type IV (MLIV), also known as sialolipidosis. MLIV is an autosomal recessive lysosomal storage disorder characterized by severe psychomotor retardation and ophthalmologic abnormalities, including corneal opacity, retinal degeneration and strabismus. Storage bodies of lipids and water-soluble substances are seen by electron microscopy in almost every cell type of the patients. Most patients are unable to speak or walk independently and reach a maximal developmental level of 1-2 years. All patients have constitutive achlorhydia associated with a secondary elevation of serum gastrin levels.
Specifications
| TRPML1 | |
| Polyclonal | |
| Unconjugated | |
| MCOLN1 | |
| 2210015I05Rik; MCLN1; Mcoln1; MCOLN1 mucolipin 1; MG-2; MGC7172; ML1; ML4; MLIV; MST080; MSTP080; Mucolipidin; mucolipidosis type IV protein; mucolipin 1; mucolipin-1; Transient receptor potential channel mucolipin 1; Transient receptor potential-mucolipin 1; TRPML1; TRP-ML1; TRPM-L1 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 57192 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Western Blot, Immunocytochemistry | |
| 0.1 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| Q9GZU1 | |
| MCOLN1 | |
| Recombinant Protein corresonding to Human TRPML1. Recombinant protein control fragment (Product #RP-95585). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction